Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

Hologic Inc Add to portfolio

INX:HOLX, Feb 22, 03:11 UTC

Latest INX:HOLX News

Filter your feed

Apply Filter

Yesterday


News

Apyx Medical's Stock Price Is About To Have A Liposuction - $3 Price Target (65% Downside) - Apyx Medical Corp (NASDAQ:APYX)

HOLX

J-Plasma use for dermal resurfacing has nasty side effects and heals very slowly - most cosmetic surgeons we have surveyed will not touch it with a 10-foot pole. The hype surrounding Apyx is predicated on the potential commercialization of its J-Plasma technology for dermal resurfacing, branded by the name of Renuvion. With electrosurgical cautery equipment becoming a commodity, Apyx sold this business in August 2018 to Symmetry Surgical for $97M. While Apyx still derives a minor portion of its revenue as an OEM supplier to Symmetry, its main focus now is on the J-plasma cosmetic surgery technology, also known as Renuvion. On April 30, 2007, Apyx acquired the remaining 50% interest in the joint venture for total consideration of $500K, resulting in the Company having 100% ownership of the J-Plasma technology. For JUMP to sell its 50% interest of J-Plasma to Apyx for only $500K means JUMP valued it in 2007 to be worth only $1M. Since 2007, 12 years ago, when the J-Plasma acquisition was made for $1M, Apyx' management:.

Read Full Details

Story Sources

seekingalpha.com
Topics:
  • Business
  • Health
News

Emerging Medical Device Technologies Market 2019-Upcoming Tech with Top Players-3M, LYRA Therapeutics, Abbott Laboratories, Alere Inc., Allergan Plc, Biotronik, Harpoon Medical, Heartware, Helioscopie, Hologic, Icellate, Illumina, Lucigen, MSDX Inc. - openPR

HOLX AGN +2 more HOLX AGN ILMN ABT

Emerging Medical Device Technologies Market 2019-Upcoming Tech with Top Players-3M, LYRA Therapeutics, Abbott Laboratories, Alere Inc., Allergan Plc, Biotronik, Harpoon Medical, Heartware, Helioscopie, Hologic, Icellate, Illumina, Lucigen, MSDX Inc. The approvals and insights on the top companies prevalent in the market will enable the reader to get accustomed with the market opportunities that they can tackle with informed and favorable business strategies. Emerging Medical Device Technologies which are relatively new (in practice over the last two to 10 years), advanced and have better outcomes in the treatment and management of world's deadly and chronic diseases. In addition, the financial overview, recent developments, SWOT analysis, product portfolio, and mergers and acquisitions in the market have been discussed in depth.

Read Full Details

Story Sources

openpr.com
Topics:
  • Business
  • Financial
  • Science
News

Hologic, Inc. (HOLX) Receives $43.35 Average Target Price from Analysts – Fairfield Current

HOLX

Shares of Hologic, Inc. (NASDAQ:HOLX) have been given a consensus recommendation of “Hold” by the nineteen research firms that are presently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating, five have issued a buy rating and one has issued a strong buy rating on the company. The company has a market capitalization of $13.05 billion, a P/E ratio of 20.01, a PEG ratio of 2.07 and a beta of 0.73. Nisa Investment Advisors LLC now owns 68,426 shares of the medical equipment provider’s stock valued at $2,804,000 after purchasing an additional 13,906 shares in the last quarter.

Read Full Details

Story Sources

fairfieldcurrent.com
Topics:
  • Business
  • Financial

Wednesday, February 20


News

Hologic, Inc. (HOLX) Sets 52-Week High at $46.51 on Feb, 20

HOLX

Hologic, Inc. (HOLX) Sets 52-Week High at $46.51 on Feb, 20. The ratio is positive due to Hologic, Inc. positioning: 35 sold and 139 reduced. Sg Americas Securities Limited Co owns 93,708 shs for 0.03% of their capital. The stock outperformed the S&P500 by 1.68%. For more Hologic, Inc. (NASDAQ:HOLX) news announced briefly go to: Seekingalpha.com, Nasdaq.com, Seekingalpha.com, Businesswire.com or Benzinga.com.

Read Full Details

Story Sources

enbulletin.com
Topics:
  • Business
  • Financial
News

Low-beta stock produce lower return: Hologic (HOLX)

HOLX

Hologic stock waking on thin line between bulls and bears tracks and with several factors it’s pulling towards optimistic side to some extend but some take to pessimistic side. So, volatility evaluation is supposed to give some wisdom of how far the stock will fall if the market takes a dive and how high the stock will rise if the bull starts to climb. For this relative risk measurement, HOLX has beta value of 0.74. Once the concept of beta is understood, an investor can intuitively determine whether or not a particular stock has a high or low beta. For example, an established blue chip company in a mature industry with stable earnings will most likely have a much lower beta compared to a start up Biotechnology Company. Many value investors look for stocks that are at or near their 52 week low, but this metric alone does not indicate whether a stock is under-valued. For example, a stock may near its 52 week low in a price correction after earnings expectations for future quarters were revised. Hologic (HOLX) stock price traded at a gap of 4.27% from an average price of last twenty days and stands at a distance of 9.03% away from it’s an average price of recent fifty days.

Read Full Details

Topics:
  • Business
  • Financial
News

Hologic, Inc. (NASDAQ:HOLX) Holding Boosted by McGuire Investment Group LLC – BharataPress

HOLX

McGuire Investment Group LLC lifted its holdings in shares of Hologic, Inc. (NASDAQ:HOLX) by 278.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. One investment analyst has rated the stock with a sell rating, nine have given a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. In other news, insider Benjamin Jordan Cohn sold 10,000 shares of the business’s stock in a transaction that occurred on Friday, November 30th. Hologic, Inc, a medical technology company, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally.

Read Full Details

Story Sources

bharatapress.com
Topics:
  • Business
  • Financial
News

Zurcher Kantonalbank Zurich Cantonalbank Has $1.89 Million Holding in Hologic, Inc. (HOLX) – BharataPress

HOLX

Zurcher Kantonalbank Zurich Cantonalbank decreased its holdings in Hologic, Inc. (NASDAQ:HOLX) by 13.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. In related news, Director Christiana Stamoulis sold 13,257 shares of the stock in a transaction dated Wednesday, November 28th. Following the completion of the sale, the director now directly owns 48,296 shares of the company’s stock, valued at approximately $2,149,172. The medical equipment provider reported $0.58 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.57 by $0.01.

Read Full Details

Story Sources

bharatapress.com
Topics:
  • Business
  • Financial
News

Beware The High Valuation: Pioneer Natural Resources Company (PXD), Hologic, Inc. (HOLX)

HOLX PXD

CATES ANDREW F., Director, bought 390 shares of the Pioneer Natural Resources Company (NYSE:PXD) in an exchange that happened on December 27th. In the past seven days, the stock price volatility for Pioneer Natural Resources Company was 2.64%, whereas its volatility in the past 30 days has been 2.39%. In the medium-term, HOLX stock has a 50-Day average volume of 2,435,482 shares and medium-term indicators gave the average rating of “ 100% Buy ”, while in the long-term period the FB stock has a 100-Day average volume of 2,257,863 shares. Needham, for example, Reiterated its rating on shares of Hologic, Inc. to a “Buy”, while setting a $50 price target on shares of the company’s stock, according to a research note from Thursday January 31st, 2019. while giving the stock a “ Underweight” from “Equal-Weight ” rating, as stated in a research report from Wednesday, January 2nd, 2019.

Read Full Details

Story Sources

nmsunews.com
Topics:
  • Business
  • Financial
News

Is this stock is Attractive? Hologic (HOLX) – Connecting Investor

HOLX

This stock traded higher toward its 52 week low with 31.88% and -0.06% down from its 52 week high price. The stock price is moving up from its 20 days moving average with 4.27% and it is trading up from 50 days moving average with 9.03%. The net percent change held by Institutional Investors has seen a change of -0.24% over last three month period. The stock price registered volatility 1.79% in past week and volatility was at 1.98% over a last month.

Read Full Details

Topics:
  • Business
  • Financial
News

Eagle Ridge Investment Management Sells 619 Shares of Hologic, Inc. (HOLX) – Fairfield Current

HOLX

Eagle Ridge Investment Management decreased its holdings in shares of Hologic, Inc. (NASDAQ:HOLX) by 0.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). Several other hedge funds have also modified their holdings of the company. Oregon Public Employees Retirement Fund boosted its holdings in shares of Hologic by 3,960.1% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 1,222,766 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 1,192,649 shares during the last quarter. Finally, Dubuque Bank & Trust Co. bought a new position in shares of Hologic during the 4th quarter valued at about $54,000. One research analyst has rated the stock with a sell rating, nine have given a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company.

Read Full Details

Story Sources

fairfieldcurrent.com
Topics:
  • Business
  • Financial